Lebwohl David 4
4 · Intellia Therapeutics, Inc. · Filed Jan 6, 2023
Insider Transaction Report
Form 4
Lebwohl David
EVP, Chief Medical Officer
Transactions
- Sale
Common Stock
2023-01-04$37.21/sh−2,574$95,779→ 25,687 total
Footnotes (1)
- [F1]Shares sold in sell-to-cover transaction in order to satisfy withholding taxes to be paid upon the vesting of RSUs on January 1, 2023.